—

Chemed Corp (CHE) — chart, structure and Closelooknet read

Pick a ticker to load its detail page.

Signals for this name

Every Closelooknet reading that exists for CHE, from the same nightly bakes the boards use. Research diary readings, not advice.

Weather around the name 3 macro readings: Money Temperature, Factor regime, Sovereign pressure

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 62/100 · S&P 500 fund at 67, bullish alignedEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-09-25
  • Factor regime Momentum leading — risk appetite buildingMomentum against low volatility (SPMO / SPLV): above its 50-day trend, 99th percentile of the window, +8.4% over 20 sessions. Factor regime → 2026-09-25
  • Sovereign pressure Index 0.61 · up 0.29 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-09-25
How it trades on rate days beta −0.01 to TLT · on the worst bond days it held up better than the market

How it trades on rate days

How CHE has moved when long-dated Treasury yields rise — measured against TLT, the 20+ year Treasury fund.

  • Beta to long bonds, 1 year −0.01 — shows only a loose link to bond moves for every 1% move in TLT (20+ year Treasuries), Chemed Corp moved −0.01% on average · correlation 0.00 · higher than 9% of US names
  • Beta, last 3 months −0.11 about the same as over the year
  • On the 10 worst bond days +0.43% on average against −0.74% for the S&P 500 the 10 sessions of the past year in which TLT fell most, i.e. long yields rose most
  • Latest of those days −0.49% TLT −1.29% that day 2026-09-24

Daily total returns from the adjusted price series; a TLT down day is a day long yields rose. Beta = the average move of the name for a 1% move in TLT. Past sensitivity, not a forecast. An investment diary, not a recommendation.

Who it is priced against Medical Care Facilities · United States · 7 names with week and year-to-date

Peer group

Medical Care Facilities · United States

This name carries no Closelooknet score, so its cohort ranks on trend state — distance to the 50- and 200-day averages — never on a score it does not have.

Compared against CHE on the nightly bakes; the Peers tab ranks the cohort on the Closelooknet scores where it exists.

Company snapshot — Chemed Corp

CHE in five paragraphs: what it makes and sells, where it sits in the Closelooknet stack, who it is priced against, why we track it, what we watch. Research diary, not advice.

What it does
Chemed operates two distinct businesses under one roof: VITAS, which provides hospice and palliative care through nurses, aides, chaplains and physicians across the United States, and Roto-Rooter, which offers plumbing, drain-clearing and water-restoration services to homes and businesses through owned branches, contractors and franchisees. The two segments share nothing operationally beyond common ownership. It is based in Cincinnati, Ohio.
Where it sits in the stack
Chemed sits outside the AI build-out entirely; it belongs to the healthcare and consumer-services corner of our wider US equity universe, grouped by its two unrelated lines of hospice care and home-repair services rather than by any technology layer.
Who it is priced against
Its own vendor description offers no peer group, so the closest comparisons the market draws are with other hospice operators, such as Amedisys, and separately with home-services franchisors like Rollins for the Roto-Rooter side.
Why Closelooknet tracks it
Chemed holds a seat in the Russell 1000; it carries no Closelooknet score yet and appears in no quoted editions of the diary so far.
What the diary watches
Whether the split between the hospice segment and the plumbing segment stays balanced, since a shift in either business changes what kind of company this actually is.

Chemed Corp (CHE) trades on US exchanges.

Written from the company’s public profile and Closelooknet’s own readings, 2026-09-17. Descriptive, refreshed with the registry; corrections welcome via the imprint. closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: index compare · sector dispersion · scanner.

The Street on this name 1 analyst action on the wire · latest: price target by UBS, 2026-09-25

The Street on this name

Analyst actions and the latest print for CHE from the Closelooknet wires — third-party opinions on the record, not our readings.

  • Price target UBS — target 650 Target set to $650 (+31.1% to spot) 2026-09-25

1 action on the analyst wire since 2026-08-13: 1 target change. Analyst wire → · Earnings wire →

Dividends and capital return trailing yield 0.49%, quarterly · last 0.70 USD on 2026-08-17

Dividends and capital return

What CHE pays out and buys back — distributions read from the price series, money terms from the filings.

  • Trailing 12 months 2.50 USD per share · a 0.49% yield on the 2026-09-25 close 4 distributions, paid quarterly 2026-09-25
  • Change on the year +19.0% against the prior twelve months prior twelve months 2.10 USD per share
  • Last distribution 0.70 USD per share as the price series records it, within days of the ex-date 2026-08-17
  • By calendar year 2024: 1.40 USD (partial) · 2025: 2.20 USD · 2026: 1.90 USD to date first distribution recorded in the three-year window: 2024-05-30

Per-share amounts are derived from the adjusted price series in the listing currency, so dates sit within days of the ex-date; filing figures come from the fundamentals feed for the last reported fiscal year. An investment diary, not a recommendation.

FAQ · from the current data · as of 2026-09-26

Quick answers

What is Chemed Corp (CHE)?

Chemed Corp trades as CHE on the US exchange (United States) in the Closelooknet research universe, as of the registry build of 2026-09-26.

Is CHE in a Closelooknet index?

Not currently — Chemed Corp is tracked in the Closelooknet research universe but is not a constituent of a Closelooknet functional index as of 2026-09-26.

Where does CHE trade against its moving averages?

Pullback inside an uptrend stack: Trades -2.1% vs the 50-day and +13.2% vs the 200-day average, 7.9% below the 52-week high and +40.4% off the 52-week low; a golden cross printed 62 sessions ago. Computed from daily closes. As of 2026-09-25 — a technical state from the nightly Closelooknet bake, not advice. The Technical tab carries the full row.

How does Chemed Corp trade when bond yields rise?

Over the past year Chemed Corp had a beta of −0.01 to TLT, the long-dated Treasury fund — it shows only a loose link to bond moves, higher than 9% of US names. On the 10 sessions in which long bonds fell most it moved +0.43% on average, against −0.74% for the S&P 500. The "How it trades on rate days" block on this page carries the lines.

What does Chemed Corp do?

Chemed operates two distinct businesses under one roof: VITAS, which provides hospice and palliative care through nurses, aides, chaplains and physicians across the United States, and Roto-Rooter, which offers plumbing, drain-clearing and water-restoration services to homes and businesses through owned branches, contractors and franchisees. The two segments share nothing operationally beyond common ownership. It is based in Cincinnati, Ohio. Its own vendor description offers no peer group, so the closest comparisons the market draws are with other hospice operators, such as Amedisys, and separately with home-services franchisors like Rollins for the Roto-Rooter side.

Where does Chemed Corp sit in the AI build-out?

Chemed sits outside the AI build-out entirely; it belongs to the healthcare and consumer-services corner of our wider US equity universe, grouped by its two unrelated lines of hospice care and home-repair services rather than by any technology layer. Chemed holds a seat in the Russell 1000; it carries no Closelooknet score yet and appears in no quoted editions of the diary so far.

Does Chemed Corp pay a dividend?

Chemed Corp has paid 2.50 USD per share over the last twelve months, paid quarterly, a trailing yield of 0.49% on the 2026-09-25 close; the last distribution recorded in the price series was 0.70 USD on 2026-08-17. The "Dividends and capital return" block on this page carries the lines.

What has Wall Street done on Chemed Corp recently?

The most recent analyst action on Chemed Corp on the Closelooknet wire is a price target by UBS on 2026-09-25 (target 650). 1 action on the analyst wire since 2026-08-13: 1 target change. Analyst actions are third-party opinions recorded by the wire, not Closelooknet readings. The “The Street on this name” block on this page lists the moves; the full feeds are the analyst wire and the earnings wire.

What does this page show?

A live price chart with SMA overlays and drawing tools for CHE, performance metrics, index-membership context and the Closelooknet structure read — an investment research diary view, not investment advice.

Related in the Closelooknet universe

then Medical Care Facilities, then Healthcare. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.